CCM
INSP icon

CAAS Capital Management’s Inspire Medical Systems INSP Stock Holding History

CAAS Capital Management’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,700
Closed -$275K – 615
2023
Q3 		$337K Buy
+1,700
New +$429K 0.02% 446

Other funds holding INSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

CAAS Capital Management's INSP Position: Q4 2023 in Review

CAAS Capital Management sold out of Inspire Medical Systems (INSP) in Q4 2023, closing a stake of 1,700 shares — an estimated $275K sold.

CAAS Capital Management first reported a position in INSP in Q3 2023 and held it in 1 quarter. The position peaked at $337K in Q3 2023. 343 funds tracked by Wall St. Rank hold INSP as of Q4 2023.

  • CAAS Capital Management reported no remaining Inspire Medical Systems position as of Q4 2023 after selling out during the quarter.
  • CAAS Capital Management sold 1,700 Inspire Medical Systems shares in Q4 2023, an estimated $275K.
  • CAAS Capital Management first reported a position in Inspire Medical Systems in Q3 2023 and held it in 1 quarter.
  • CAAS Capital Management's Inspire Medical Systems position peaked at $337K in Q3 2023.
  • 343 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2023.

Based on CAAS Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.